Induction of the activating transcription factor-4 in the intratumoral CD8+ T cells sustains their viability and anti-tumor activities
Zhen Lu(Shanghai Zhangjiang Laboratory), Serge Y. Fuchs(University of Pennsylvania)
Cited by 12
Related Papers
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models
|Science Translational Medicine|2021|139
Impaired Turnover of Prolactin Receptor Contributes to Transformation of Human Breast Cells
|Cancer Research|2009|51
Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer
|Nature Communications|2022|33
Regulation of intercellular biomolecule transfer–driven tumor angiogenesis and responses to anticancer therapies
|Journal of Clinical Investigation|2021|20